Hard to Treat Diseases Inc. (HTDS)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Nov 9, 2026
Hard to Treat Diseases Market Cap
Hard to Treat Diseases has a market cap or net worth of $5.82 thousand as of November 10, 2026. It is the 52,067th most valuable company in the world and the 7,992nd biggest in the United States.
Market Cap
5.82K
Enterprise Value
n/a
Revenue
6.16M
Global Rank
Country Rank
#7,992 United States
PE Ratio
0.01
ChartMarket Cap Chart
Since February 20, 2009, Hard to Treat Diseases's market cap has decreased from 56.96K to 5.82K, a decrease of -89.78%. That is a compound annual growth rate of -12.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 5.82K | - |
| Dec 31, 2025 | 5.82K | - |
| Dec 31, 2024 | 5.82K | - |
| Dec 29, 2023 | 5.82K | - |
| Dec 30, 2022 | 5.82K | - |
| Dec 31, 2021 | 5.82K | -99.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioasis Technologies | 7.94K |
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.17K |
| Theralink Technologies | 6.15K |
| FluoroPharma Medical | 5.52K |
| Better Therapeutics | 5.45K |
| LadRx | 5.45K |
| Aridis Pharmaceuticals | 5.33K |